Cryptococcal meningitis occurring at 19 months after cladribine therapy for hairy cell leukemia.
Ikpeazu
E V
EV
Kaplon
M K
MK
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017338:Cladribine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D008297:Male; D016919:Meningitis, Cryptococcal / Q000209:etiology* / Q000503:physiopathology; D008875:Middle Aged
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D017338:Cladribine